4.4.9.3Vertical
Chronic Disease Management
Companies delivering disease management programs for at-risk patients.
Market snapshot
These figures describe Population Health Management (4.4.9), the segment that Chronic Disease Management sits within — not Chronic Disease Management on its own.
FragmentationConsolidatingEstimate
No discrete Census NAICS code — population-health and VBC enablement sit within healthcare-services and technology classifications, so the segment is not separately sized by the Census Bureau.
Business model & economics
Revenue model
Shared-savings, capitation, and enablement fees
Key economics
- Recurring revenue
- High
- EBITDA margin
- Risk- and execution-dependent
- Capex intensity
- Low
risk-bearing and platform contracts
Characteristics
- Central to the fee-for-service-to-value-based shift.
- Medicare Advantage and ACO programs drive growth.
- Risk-bearing economics and analytics define the model.
M&A deal context
Deal activityHigh
Who’s acquiring
- Value-based-care enablement platforms
- Payer & provider strategics
- PE- and VC-backed investors
What’s driving deals
- Value-based-care transition and risk adoption.
- Medicare Advantage and ACO growth.
- Data-and-analytics-driven consolidation.
Find Chronic Disease Management acquisition targets
Search Acquisera’s index for companies classified under Chronic Disease Management (4.4.9.3) and build a targeted deal pipeline.
Search companies